5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the FDA since April 27.

Advertisement

1. Plenvu is a liquid drug patients can drink to cleanse their bowels before a colonoscopy.

2. Novartis’ combination therapy of Tafinlar and Mekinist may now be used to treat an aggressive form of thyroid cancer.

3. Hemospray is an aerosolized spray designed to help control bleeding in the gastrointestinal tract.

4. Kymriah may now be used to treat patients with large B-cell lymphoma whose cancer has progressed after at least two previous therapies.

5. The Attest Super Rapid Biological Indicator System for Steam provides readings on both steam and vaporized hydrogen peroxide biological indicators in 24 minutes.

More articles on supply chain:
Meet the 10 participants in the US drone program
FDA issues EpiPen shortage alert: 6 things to know
A new pharma giant —Takeda acquires Shire for $62B

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.